Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010179644 | QH585.5.E48 E44 2008 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
At the time of the lightbulb's invention, not even the most imaginative thinkers could have predicted the prevention and treatment of disease through genes delivered by electric fields. In Electroporation Protocols: Preclinicaland Clinical Gene Medicine, top researchers provide hands-on protocols describing the process of non-viral delivery of genetic materials such as DNA, oligo-DNA, and RNA into targeted immune cells, tissues, and model animals in order to better treat disease. Following the successful Methods in Molecular Biology(tm) series format, each method and protocol offers step-by-step, readily reproducible laboratory instructions, with the benefit of several introductory reviews to aid investigators new to this exciting technology.
Table of Contents
Preface | p. v |
Contributors | p. xiii |
Part I Basic Concepts of DNA Transfer via Electroporation | |
Chapter 1 Application of Electroporation Gene Therapy: Past, Current, and Future | p. 3 |
Chapter 2 Mechanism by Which Electroporation Mediates DNA Migration and Entry into Cells and Targeted Tissues | p. 19 |
Chapter 3 Applicator and Electrode Design for In Vivo DNA Delivery by Electroporation | p. 35 |
Chapter 4 Electrode Assemblies Used for Electroporation of Cultured Cells | p. 61 |
Chapter 5 Formulations for DNA Delivery via Electroporation In Vivo | p. 77 |
Chapter 6 Overview of Drug Delivery and Alternative Methods to Electroporation | p. 91 |
Chapter 7 Nanoelectroporation: A First Look | p. 109 |
Part II In Vitro Targeted Gene Delivery via Electroporation | |
Chapter 8 Nucleofection of Human Embryonic Stem Cells | p. 131 |
Chapter 9 Delivery of Whole Tumor Lysate into Dendritic Cells for Cancer Vaccination | p. 139 |
Chapter 10 Delivery of Tumor-Antigen-Encoding mRNA into Dendritic Cells for Vaccination | p. 155 |
Chapter 11 Delivery of DNA into Natural Killer Cells for Immunotherapy | p. 165 |
Chapter 12 Electroporation of Adherent Cells In Situ for the Study of Signal Transduction and Gap Junctional Communication | p. 173 |
Chapter 13 Delivery of DNA into Adipocytes within Adipose Tissue | p. 191 |
Part III In Vivo Targeted Gene Delivery via Electroporation | |
Chapter 14 Delivery of DNA into Muscle for Treating Systemic Diseases: Advantages and Challenges | p. 199 |
Chapter 15 Delivery of DNA into Skeletal Muscle in Large Animals | p. 215 |
Chapter 16 Delivery of DNA into Skin via Electroporation | p. 225 |
Chapter 17 Electroporation-Mediated Gene Delivery to the Lungs | p. 233 |
Chapter 18 Delivery of DNA into Bladder via Electroporation | p. 249 |
Chapter 19 Analysis of Gene Function in the Retina | p. 259 |
Chapter 20 Optical In Vivo Imaging of Electrically Mediated Delivery of siRNA into Muscle for Gene Function Analysis | p. 279 |
Chapter 21 Electroporation of Adult Zebrafish | p. 289 |
Part IV Treatment of Cancer via Electroporation Gene Therapy | |
Chapter 22 Flow Electroporation with Pulsed Electric Fields for Purging Tumor Cells | p. 301 |
Chapter 23 Delivery of DNA into Tumors | p. 311 |
Chapter 24 Intratumoral Bleomycin and IL-12 Electrochemogenetherapy for Treating Head and Neck Tumors in Dogs | p. 319 |
Chapter 25 Systemic IL-12 Gene Therapy for Treating Malignancy via Intramuscular Electroporation | p. 327 |
Chapter 26 Treatment of SCCVII Tumors with Systemic Chemotherapy and Interleukin-12 Gene Therapy Combination | p. 339 |
Chapter 27 Electroporation for Drug and Gene Delivery in the Clinic: Doctors Go Electric | p. 351 |
Chapter 28 IL-2 Plasmid Electroporation: From Preclinical Studies to Phase I Clinical Trial | p. 361 |
Part V Treatment of Other Diseases via Electroporation Gene Therapy | |
Chapter 29 Factor IX Gene Therapy for Hemophilia | p. 375 |
Chapter 30 KGF-1 for Wound Healing in Animal Models | p. 383 |
Chapter 31 Hepatocyte Growth Factor Gene Therapy for Hypertension | p. 393 |
Chapter 32 Electroporation of Corrective Nucleic Acids (CNA) In Vivo to Promote Gene Correction in Dystrophic Muscle | p. 405 |
Chapter 33 Gene Delivery to Dystrophic Muscle | p. 421 |
Chapter 34 Effect of Electroporation on Cardiac Electrophysiology | p. 433 |
Chapter 35 Muscle and Fat Mass Modulation in Different Clinical Models | p. 449 |
Part VI Applications of Electroporation for DNA Vaccination | |
Chapter 36 DNA Vaccination for Prostate Cancer | p. 463 |
Chapter 37 HER2/neu DNA Vaccination for Breast Tumors | p. 473 |
Chapter 38 Electroporation-Mediated HBV DNA Vaccination in Primate Models | p. 487 |
Chapter 39 Taking Electroporation-Based Delivery of DNA Vaccination into Humans: A Generic Clinical Protocol | p. 497 |
Chapter 40 Production of Monoclonal Antibody by DNA Immunization with Electroporation | p. 509 |
Index | p. 521 |